Journal Cover
The Lancet
Journal Prestige (SJR): 14.934
Citation Impact (citeScore): 9
Number of Followers: 2848  
 
  Full-text available via subscription Subscription journal
ISSN (Print) 0140-6736 - ISSN (Online) 1474-547X
Published by Elsevier Homepage  [3147 journals]
  • Scotland to ban heading in children's football
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Nayanah Siva
       
  • Focus on snake ecology to fight snakebite
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Kris A Murray, Gerardo Martin, Takuya Iwamura
       
  • Department of Error
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s):
       
  • Department of Error
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s):
       
  • Department of Error
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s):
       
  • This is not the EAT–Lancet Diet – Authors' reply
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Keren Papier, Anika Knuppel, Timothy J Key, Ruth C Travis
       
  • This is not the EAT–Lancet Diet
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Zoe Harcombe
       
  • Faecal microbiota transplantations and urinary tract infections –
           Authors' reply
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Jessica R Allegretti, Benjamin H Mullish
       
  • Faecal microbiota transplantations and urinary tract infections
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Jean Christophe Lagier, Didier Raoult
       
  • Atrasentan in patients with diabetes and chronic kidney disease –
           Authors' reply
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Hiddo J L Heerspink, Hans-Henrik Parving, Dick de Zeeuw
       
  • Atrasentan in patients with diabetes and chronic kidney disease
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Dongwei Liu, Zhangsuo Liu
       
  • Atrasentan in patients with diabetes and chronic kidney disease
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Vincenzo Sepe, Carmelo Libetta
       
  • The invisible burden of malaria-attributable stillbirths – Authors'
           reply
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Peter Gething, Simon Hay, Daniel Weiss
       
  • The invisible burden of malaria-attributable stillbirths
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Freya J I Fowkes, Eliza Davidson, Kerryn A Moore, Rose McGready, Julie A Simpson
       
  • Use of copeptin in the diagnosis of polyuria-polydipsia syndrome –
           Authors' reply
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Bettina Winzeler, Mirjam Christ-Crain
       
  • Use of copeptin in the diagnosis of polyuria-polydipsia syndrome
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Judith E Heida, Ron T Gansevoort, André P van Beek
       
  • Fitzhugh Mullan
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Geoff Watts
       
  • The power of play
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Justine Howard
       
  • Humanitarian crises: needs grow as health funding falls
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): John Zarocostas
       
  • Pseudoaneurysm in a patient with haemophilia A: thrombin injection plugs
           the hole
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Geoffrey C Colin, Patrick Mailleux, Anne-Catherine Bafort, Christophe Van Bellinghen, François Buche
       
  • Fears over plan to privatise India's district hospitals
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Dinesh C Sharma
       
  • Offline: Scientific publishing—trust and tribulations
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Richard Horton
       
  • An ethically mindful approach to AI for health care
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Jessica Morley, Luciano Floridi
       
  • Eplerenone is not superior to placebo for chronic central serous
           chorioretinopathy
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Alessandro Rabiolo, Francesco Bandello
       
  • Simple and safe: preventing preterm birth with aspirin
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): Julie A Quinlivan
       
  • Ending childhood violence in Europe
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): The Lancet
       
  • Doctors and civil disobedience
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): The Lancet
       
  • The antimicrobial crisis: enough advocacy, more action
    • Abstract: Publication date: 25–31 January 2020Source: The Lancet, Volume 395, Issue 10220Author(s): The Lancet
       
  • Clinical features of patients infected with 2019 novel coronavirus in
           Wuhan, China
    • Abstract: Publication date: Available online 24 January 2020Source: The LancetAuthor(s): Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu, Zhenshun Cheng, Ting Yu, Jiaan Xia, Yuan Wei, Wenjuan Wu, Xuelei Xie, Wen Yin, Hui Li, Min Liu, Yan XiaoSummaryBackgroundA recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients.MethodsAll patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan. We prospectively collected and analysed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing. Data were obtained with standardised data collection forms shared by the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records. Researchers also directly communicated with patients or their families to ascertain epidemiological and symptom data. Outcomes were also compared between patients who had been admitted to the intensive care unit (ICU) and those who had not.FindingsBy Jan 2, 2020, 41 admitted hospital patients had been identified as having laboratory-confirmed 2019-nCoV infection. Most of the infected patients were men (30 [73%] of 41); less than half had underlying diseases (13 [32%]), including diabetes (eight [20%]), hypertension (six [15%]), and cardiovascular disease (six [15%]). Median age was 49·0 years (IQR 41·0–58·0). 27 (66%) of 41 patients had been exposed to Huanan seafood market. One family cluster was found. Common symptoms at onset of illness were fever (40 [98%] of 41 patients), cough (31 [76%]), and myalgia or fatigue (18 [44%]); less common symptoms were sputum production (11 [28%] of 39), headache (three [8%] of 38), haemoptysis (two [5%] of 39), and diarrhoea (one [3%] of 38). Dyspnoea developed in 22 (55%) of 40 patients (median time from illness onset to dyspnoea 8·0 days [IQR 5·0–13·0]). 26 (63%) of 41 patients had lymphopenia. All 41 patients had pneumonia with abnormal findings on chest CT. Complications included acute respiratory distress syndrome (12 [29%]), RNAaemia (six [15%]), acute cardiac injury (five [12%]) and secondary infection (four [10%]). 13 (32%) patients were admitted to an ICU and six (15%) died. Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα.InterpretationThe 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was associated with ICU admission and high mortality. Major gaps in our knowledge of the origin, epidemiology, duration of human transmission, and clinical spectrum of disease need fulfilment by future studies.FundingMinistry of Science and Technology, Chinese Academy of Medical Sciences, National Natural Science Foundation of China, and Beijing Municipal Science and Technology Commission.
       
  • A familial cluster of pneumonia associated with the 2019 novel coronavirus
           indicating person-to-person transmission: a study of a family cluster
    • Abstract: Publication date: Available online 24 January 2020Source: The LancetAuthor(s): Jasper Fuk-Woo Chan, Shuofeng Yuan, Kin-Hang Kok, Kelvin Kai-Wang To, Hin Chu, Jin Yang, Fanfan Xing, Jieling Liu, Cyril Chik-Yan Yip, Rosana Wing-Shan Poon, Hoi-Wah Tsoi, Simon Kam-Fai Lo, Kwok-Hung Chan, Vincent Kwok-Man Poon, Wan-Mui Chan, Jonathan Daniel Ip, Jian-Piao Cai, Vincent Chi-Chung Cheng, Honglin Chen, Christopher Kim-Ming HuiSummaryBackgroundAn ongoing outbreak of pneumonia associated with a novel coronavirus was reported in Wuhan city, Hubei province, China. Affected patients were geographically linked with a local wet market as a potential source. No data on person-to-person or nosocomial transmission have been published to date.MethodsIn this study, we report the epidemiological, clinical, laboratory, radiological, and microbiological findings of five patients in a family cluster who presented with unexplained pneumonia after returning to Shenzhen, Guangdong province, China, after a visit to Wuhan, and an additional family member who did not travel to Wuhan. Phylogenetic analysis of genetic sequences from these patients were done.FindingsFrom Jan 10, 2020, we enrolled a family of six patients who travelled to Wuhan from Shenzhen between Dec 29, 2019 and Jan 4, 2020. Of six family members who travelled to Wuhan, five were identified as infected with the novel coronavirus. Additionally, one family member, who did not travel to Wuhan, became infected with the virus after several days of contact with four of the family members. None of the family members had contacts with Wuhan markets or animals, although two had visited a Wuhan hospital. Five family members (aged 36–66 years) presented with fever, upper or lower respiratory tract symptoms, or diarrhoea, or a combination of these 3–6 days after exposure. They presented to our hospital (The University of Hong Kong-Shenzhen Hospital, Shenzhen) 6–10 days after symptom onset. They and one asymptomatic child (aged 10 years) had radiological ground-glass lung opacities. Older patients (aged>60 years) had more systemic symptoms, extensive radiological ground-glass lung changes, lymphopenia, thrombocytopenia, and increased C-reactive protein and lactate dehydrogenase levels. The nasopharyngeal or throat swabs of these six patients were negative for known respiratory microbes by point-of-care multiplex RT-PCR, but five patients (four adults and the child) were RT-PCR positive for genes encoding the internal RNA-dependent RNA polymerase and surface Spike protein of this novel coronavirus, which were confirmed by Sanger sequencing. Phylogenetic analysis of these five patients' RT-PCR amplicons and two full genomes by next-generation sequencing showed that this is a novel coronavirus, which is closest to the bat severe acute respiatory syndrome (SARS)-related coronaviruses found in Chinese horseshoe bats.InterpretationOur findings are consistent with person-to-person transmission of this novel coronavirus in hospital and family settings, and the reports of infected travellers in other geographical regions.FundingThe Shaw Foundation Hong Kong, Michael Seak-Kan Tong, Respiratory Viral Research Foundation Limited, Hui Ming, Hui Hoy and Chow Sin Lan Charity Fund Limited, Marina Man-Wai Lee, the Hong Kong Hainan Commercial Association South China Microbiology Research Fund, Sanming Project of Medicine (Shenzhen), and High Level-Hospital Program (Guangdong Health Commission).
       
  • Cultivating awareness of the Holocaust in medicine
    • Abstract: Publication date: Available online 24 January 2020Source: The LancetAuthor(s): Diethard Tauschel, Peter Selg, Friedrich Edelhäuser, Andrea Witowski, Hedy S Wald
       
  • Cultivating awareness of the Holocaust in medicine
    • Abstract: Publication date: Available online 24 January 2020Source: The LancetAuthor(s): Deanna Anderlini
       
  • Emerging understandings of 2019-nCoV
    • Abstract: Publication date: Available online 24 January 2020Source: The LancetAuthor(s): The Lancet
       
  • Data sharing and outbreaks: best practice exemplified
    • Abstract: Publication date: Available online 24 January 2020Source: The LancetAuthor(s): David L Heymann
       
  • Cultivating awareness of the Holocaust in medicine
    • Abstract: Publication date: Available online 24 January 2020Source: The LancetAuthor(s): Stacy Gallin, Tessa Chelouche, Shmuel Reis, Hedy S Wald, Matthew Wynia
       
  • A novel coronavirus outbreak of global health concern
    • Abstract: Publication date: Available online 24 January 2020Source: The LancetAuthor(s): Chen Wang, Peter W Horby, Frederick G Hayden, George F Gao
       
  • Department of Error
    • Abstract: Publication date: Available online 23 January 2020Source: The LancetAuthor(s):
       
  • Running thin: implications of a heparin shortage
    • Abstract: Publication date: Available online 23 January 2020Source: The LancetAuthor(s): Cian P McCarthy, Muthiah Vaduganathan, Edmond Solomon, Rahul Sakhuja, Gregory Piazza, Deepak L Bhatt, Jean M Connors, Nilay K Patel
       
  • Attention-deficit hyperactivity disorder
    • Abstract: Publication date: Available online 23 January 2020Source: The LancetAuthor(s): Jonathan Posner, Guilherme V Polanczyk, Edmund Sonuga-BarkeSummaryAttention-deficit hyperactivity disorder (ADHD), like other psychiatric disorders, represents an evolving construct that has been refined and developed over the past several decades in response to research into its clinical nature and structure. The clinical presentation and course of the disorder have been extensively characterised. Efficacious medication-based treatments are available and widely used, often alongside complementary psychosocial approaches. However, their effectiveness has been questioned because they might not address the broader clinical needs of many individuals with ADHD, especially over the longer term. Non-pharmacological approaches to treatment have proven less effective than previously thought, whereas scientific and clinical studies are starting to fundamentally challenge current conceptions of the causes of ADHD in ways that might have the potential to alter clinical approaches in the future. In view of this, we first provide an account of the diagnosis, epidemiology, and treatment of ADHD from the perspective of both the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders and the eleventh edition of the International Classification of Diseases. Second, we review the progress in our understanding of the causes and pathophysiology of ADHD on the basis of science over the past decade or so. Finally, using these discoveries, we explore some of the key challenges to both the current models and the treatment of ADHD, and the ways in which these findings can promote new perspectives.
       
  • Population-level impact of human papillomavirus vaccination
    • Abstract: Publication date: Available online 21 January 2020Source: The LancetAuthor(s): Maria Brotons, Laia Bruni
       
  • Population-level impact of human papillomavirus vaccination –
           Authors' reply
    • Abstract: Publication date: Available online 21 January 2020Source: The LancetAuthor(s): Mélanie Drolet, Marc Brisson
       
  • Population-level impact of human papillomavirus vaccination
    • Abstract: Publication date: Available online 21 January 2020Source: The LancetAuthor(s): Peter Sasieni, Jack Cuzick
       
  • Trial results reporting: FDA Amendments Act Final Rule needs enforcement
    • Abstract: Publication date: Available online 17 January 2020Source: The LancetAuthor(s): Erik von Elm, Joerg J Meerpohl
       
  • Oral diseases: a global public health challenge – Authors' reply
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Marco A Peres, Blánaid Daly, Carol C Guarnizo-Herreño, Habib Benzian, Richard G Watt
       
  • Infectious mononucleosis diagnosed by Downey cells: sometimes the old ways
           are better
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Henry M Feder, William N Rezuke
       
  • Life-threatening hyperkalaemia after succinylcholine – Authors'
           reply
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Anne-Flore Plane, Pierre-Emmanuel Marsan, Damien du Cheyron, Xavier Valette
       
  • Life-threatening hyperkalaemia after succinylcholine
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Jamie Strachan, Matthew Frise
       
  • Optimising first-line treatment for metastatic renal cell carcinoma
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Fei Liang
       
  • Optimising first-line treatment for metastatic renal cell carcinoma
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Guillermo de Velasco
       
  • Optimising first-line treatment for metastatic renal cell carcinoma
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Elif Hindié
       
  • Department of Error
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s):
       
  • Prophylactic antibiotics after operative vaginal delivery – Author's
           reply
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Marian Knight, ANODE collaborative group
       
  • Prophylactic antibiotics after operative vaginal delivery
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Kaho Iwabu, Yuto Maeda, Tetsuya Tanimoto
       
  • Prophylactic antibiotics after operative vaginal delivery
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Petra Zimmermann, Nigel Curtis
       
  • Prophylactic antibiotics after operative vaginal delivery
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Martin J Blaser, Brian L Strom, Maria G Dominguez Bello
       
  • Prophylactic antibiotics after operative vaginal delivery
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Lena Sagi-Dain, Shlomi Sagi, Reuven Kedar, Mordechai Bardicef, Eli Gutterman
       
  • Prophylactic antibiotics after operative vaginal delivery
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Kelly Jane Thompson, Jane Elizabeth Hirst
       
  • Oral diseases: a global public health challenge
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Jean-Noel Vergnes, Marco Mazevet
       
  • Oral diseases: a global public health challenge
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Himmatrao Saluba Bawaskar, Pramodini Himmatrao Bawaskar
       
  • Pakistan's children need better protection by the health-care system
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Mishal Khan
       
  • Tetsu Nakamura
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Andrew Green
       
  • Indian health care caught up in violence
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Anoo Bhuyan
       
  • Bushfires expose weaknesses in Australia's health system
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Sophie Cousins
       
  • Offline: After 2000 years, an answer arrives
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Richard Horton
       
  • Rebuilding Sudan's health system: opportunities and challenges
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): George Wharton, Omar E Ali, Siddiq Khalil, Hatim Yagoub, Elias Mossialos
       
  • Femtosecond laser-assisted vs conventional cataract surgery
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Alexander C Day, Oliver Findl
       
  • A global accounting of sepsis
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Jordan A Kempker, Greg S Martin
       
  • Patients with left main coronary artery disease: stent or surgery'
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): Marie-Claude Morice
       
  • Trump's steady erosion of health insurance protections
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): The Lancet
       
  • Protecting health research in the UK: culture and collaboration
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): The Lancet
       
  • Australia on fire
    • Abstract: Publication date: 18–24 January 2020Source: The Lancet, Volume 395, Issue 10219Author(s): The Lancet
       
  • Department of Error
    • Abstract: Publication date: Available online 16 January 2020Source: The LancetAuthor(s):
       
  • EU migration policies drive health crisis on Greek islands
    • Abstract: Publication date: Available online 13 January 2020Source: The LancetAuthor(s): Miriam Orcutt, Reem Mussa, Lucinda Hiam, Apostolos Veizis, Sophie McCann, Elisavet Papadimitriou, Aurelie Ponthieu, Michael Knipper
       
  • Addressing sociopolitical determinants of mental health: an emerging
           challenge in Hong Kong
    • Abstract: Publication date: Available online 9 January 2020Source: The LancetAuthor(s): Xue Yang, Winnie W S Mak
       
  • Department of Error
    • Abstract: Publication date: Available online 9 January 2020Source: The LancetAuthor(s):
       
  • The cognitive health system
    • Abstract: Publication date: Available online 7 January 2020Source: The LancetAuthor(s): Enrico Coiera
       
  • Wakley–Wu Lien Teh Prize Essay 2019: two generations of Chinese
           doctors
    • Abstract: Publication date: Available online 26 December 2019Source: The LancetAuthor(s): Esther Lau, Helena Hui Wang, Richard Horton
       
  • 给父亲的一封信
    • Abstract: Publication date: Available online 26 December 2019Source: The LancetAuthor(s): 文斐 谭
       
  • Should health professionals participate in civil disobedience in response
           to the climate change health emergency'
    • Abstract: Publication date: Available online 7 December 2019Source: The LancetAuthor(s): Hayley Bennett, Alexandra Macmillan, Rhys Jones, Alison Blaiklock, John McMillan
       
  • My arrest in support of Extinction Rebellion: the imperative for action
    • Abstract: Publication date: Available online 7 December 2019Source: The LancetAuthor(s): Robin Stott
       
  • Patients' rights in Kashmir
    • Abstract: Publication date: Available online 4 September 2019Source: The LancetAuthor(s): Muhammad Magdi Yaqoob, Kieran McCafferty
       
  • Humanitarian crisis in Kashmir: don't shoot the messenger
    • Abstract: Publication date: Available online 4 September 2019Source: The LancetAuthor(s): Zafar Mirza
       
  • Kashmir and The Lancet
    • Abstract: Publication date: Available online 4 September 2019Source: The LancetAuthor(s): Santanu Sen, R V Asokan
       
  • India's concern for Kashmir
    • Abstract: Publication date: Available online 4 September 2019Source: The LancetAuthor(s): Abdul Ghafur
       
  • Kashmir and medical education
    • Abstract: Publication date: Available online 4 September 2019Source: The LancetAuthor(s): Tanveer P Mir
       
  • Kashmir in The Lancet
    • Abstract: Publication date: Available online 4 September 2019Source: The LancetAuthor(s): Avadhoot Kantak
       
  • The complex challenges of HIV vaccine development require renewed and
           expanded global commitment
    • Abstract: Publication date: Available online 2 December 2019Source: The LancetAuthor(s): Linda-Gail Bekker, Roger Tatoud, Francois Dabis, Mark Feinberg, Pontiano Kaleebu, Mary Marovich, Thumbi Ndung'u, Nina Russell, Jeremiah Johnson, Maureen Luba, Anthony S Fauci, Lynn Morris, Giuseppe Pantaleo, Susan Buchbinder, Glenda Gray, Johan Vekemans, Jerome H Kim, Yves Levy, Lawrence Corey, Robin Shattock
       
  • Unacceptable failures: the final report of the Lancet Commission into
           liver disease in the UK
    • Abstract: Publication date: Available online 29 November 2019Source: The LancetAuthor(s): Roger Williams, Guruprasad Aithal, Graeme J Alexander, Michael Allison, Iain Armstrong, Richard Aspinall, Alastair Baker, Rachel Batterham, Katrina Brown, Robyn Burton, Matthew E Cramp, Natalie Day, Anil Dhawan, Colin Drummond, James Ferguson, Graham Foster, Ian Gilmore, Jonny Greenberg, Clive Henn, Helen JarvisSummaryThis final report of the Lancet Commission into liver disease in the UK stresses the continuing increase in burden of liver disease from excess alcohol consumption and obesity, with high levels of hospital admissions which are worsening in deprived areas. Only with comprehensive food and alcohol strategies based on fiscal and regulatory measures (including a minimum unit price for alcohol, the alcohol duty escalator, and an extension of the sugar levy on food content) can the disease burden be curtailed. Following introduction of minimum unit pricing in Scotland, alcohol sales fell by 3%, with the greatest effect on heavy drinkers of low-cost alcohol products. We also discuss the major contribution of obesity and alcohol to the ten most common cancers as well as measures outlined by the departing Chief Medical Officer to combat rising levels of obesity—the highest of any country in the west. Mortality of severely ill patients with liver disease in district general hospitals is unacceptably high, indicating the need to develop a masterplan for improving hospital care. We propose a plan based around specialist hospital centres that are linked to district general hospitals by operational delivery networks. This plan has received strong backing from the British Association for Study of the Liver and British Society of Gastroenterology, but is held up at NHS England. The value of so-called day-case care bundles to reduce high hospital readmission rates with greater care in the community is described, along with examples of locally derived schemes for the early detection of disease and, in particular, schemes to allow general practitioners to refer patients directly for elastography assessment. New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country. Understanding of the harm to health from lifestyle causes among the general population is low, with a poor knowledge of alcohol consumption and dietary guidelines. The Lancet Commission has serious doubts about whether the initiatives described in the Prevention Green Paper, with the onus placed on the individual based on the use of information technology and the latest in behavioural science, will be effective. We call for greater coordination between official and non-official bodies that have highlighted the unacceptable disease burden from liver disease in England in order to present a single, strong voice to the higher echelons of government.
       
  • Monitoring the health-related Sustainable Development Goals: lessons
           learned and recommendations for improved measurement
    • Abstract: Publication date: Available online 22 November 2019Source: The LancetAuthor(s): Samira Asma, Rafael Lozano, Somnath Chatterji, Soumya Swaminathan, Maria de Fátima Marinho, Naoko Yamamoto, Elena Varavikova, Awoke Misganaw, Michael Ryan, Lalit Dandona, Ren Minghui, Christopher J L Murray
       
  • Integration of Kashmir for peace and prosperity
    • Abstract: Publication date: Available online 4 September 2019Source: The LancetAuthor(s): Mahaveer Golechha
       
  • Department of Error
    • Abstract: Publication date: Available online 6 September 2019Source: The LancetAuthor(s):
       
  • Department of Error
    • Abstract: Publication date: Available online 31 October 2019Source: The LancetAuthor(s):
       
  • Department of Error
    • Abstract: Publication date: Available online 7 October 2019Source: The LancetAuthor(s):
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 3.229.142.175
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-